r-hLH

DRUG2 trials

Sponsors

Merck KGaA, Darmstadt, Germany

Conditions

InfertilityOvarian Stimulation

Phase 2

Lutropin Alfa in Women at Risk of Poor Response

CompletedNCT01112358

Merck KGaA, Darmstadt, GermanyOvarian Stimulation

Start: 2005-12-07End: 2007-01-30Updated: 2018-08-28

A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

CompletedNCT01735422

Merck KGaA, Darmstadt, GermanyInfertility

Start: 1999-12-31End: 2001-07-31Updated: 2014-02-04